Sculpt your body

Results for

Up to 93% of patients surveyed were satisfied with their CoolSculpting® treatment.∞

As the world leaders in fat freezing treatment, CoolSculpting® is effective at reshaping bodies - achieving up to 27% fat reduction across multiple treated areas.

See real results and some of the different areas where you can freeze away stubborn superficial fat for good.°

Abdomen

There are some pockets of superficial fat in your body even diet and exercise can’t shift. Within 6 months you may see up to 27% reduction in your abdomen.x

24.5 WEEKS AFTER first CoolSculpting® session (16 weeks after second CoolSculpting® session). Patient received total of 18 treatment cycles over 3 CoolSculpting® sessions on the lower abdomen, mid abdomen, flank, lower bra and mons pubis. Photo courtesy of Allergan Aesthetics, an AbbVie Company.

Thigh

91% patient satisfaction with treatment has been shown following treatment for stubborn pockets of superficial fat in the inner thigh–

Treat your thighs today.

25 WEEKS AFTER first CoolSculpting® session (12 weeks after second CoolSculpting® session). Patient received total of 6 treatment cycles over 2 CoolSculpting® sessions on the inner and outer thigh. Photo courtesy of Dr Joseph Jensen.

Can CoolSculpting® treat my chin?

Are you part of the 73% of consumers bothered by excess fat under their neck/chin? †
You may achieve up to 20% reduction in the fat layer following treatment under your chin.~

 

27.5 WEEKS AFTER first CoolSculpting® session (18.5 weeks after second CoolSculpting® session). Patient received total of 4 treatment cycles over 2 CoolSculpting® sessions on the submental area. Photo courtesy of Allergan Aesthetics, an AbbVie Company.

Contour your curves

Freeze away your stubborn superficial fat for good.°

You could reduce your love handles (sides/flanks) as much as 25% with CoolSculpting®, and can help reduce the fat around your bra bands by 20%.∂

27.5 WEEKS AFTER first CoolSculpting® session (18.5 weeks after second CoolSculpting® session). Patient received total of 7 treatment cycles over 2 CoolSculpting® sessions on the upper flanks and lower bra area. Photo courtesy of Allergan Aesthetics, an AbbVie Company.

Upper Arms

Following their treatment with CoolSculpting® on the upper arm, 83% of patients were satisfied with their results.◊

27.5 WEEKS AFTER first CoolSculpting® session (14 weeks after second CoolSculpting® session). Patient receive total of 4 treatment cycles over 2 CoolSculpting® sessions on the upper arms. Photo courtesy of Allergan Aesthetics, an AbbVie Company.

Find a clinic

Please enter a valid address. Please enter a location.

∞Patients surveyed between 3-4 months after completion of at least one treatment cycle
°Data obtained from cryolipolysis investigations using a porcine model
×Average 27% fat reduction seen at 6-month follow-up in n=55 patients treated on the lower abdomen
–Patient survey (N=11 study patients; 16 weeks post-treatment)
†Online survey across 27 countries in 2016/17 of 32,570
~The mean 2.0 mm reduction correlated to a mean 20% submental fat layer reduction (n=60)
∂Average 27% fat reduction seen at 6-month follow-up in n=55 patients treated on the lower abdomen. Other body sites evaluated included brasserie rolls (20%), lumbar rolls (22%), hip rolls (25%), inner thighs (17%) and medial knees (18%). The average fat reduction at 6 months across all sites was 21.5%
◊Results were self-evaluated. Following treatment, 83.3% (N=5) reported satisfactory result (Total study, N=7 study patients [n=6 available for follow-up]; 8 weeks post-treatment)

A HEALTHY DIET AND EXERCISE ARE IMPORTANT. COOLSCULPTING® IS NOT A WEIGHT LOSS PROCEDURE AND SHOULD NOT REPLACE A HEALTHY DIET AND ACTIVE LIFESTYLE.

This Medical Device must be applied by a healthcare professional. Always read and follow the instructions. The CoolSculpting® procedure is not for everyone. Patients should not have the CoolSculpting® procedure if they suffer from cryoglobulinaemia, cold agglutinin disease or paroxysmal cold haemoglobinuria. Be careful using CoolSculpting® in pregnant or breastfeeding women, in patients who are sensitive to cold or to fructose, glycerin, isopropyl alcohol or propylene glycol; in patients with poor circulation, recent surgery, scar tissue, skin conditions such as eczema, dermatitis, or rashes in the area to be treated, nerve pain following shingles, nerve damage due to diabetes, poor skin sensation, open or infected wounds, bleeding disorders or use of blood thinners hernia in or near the area to be treated; and in patients with implanted pacemakers and defibrillators. The device is not intended to cause weight loss or to treat obesity.

During the procedure patients may experience sensations of pulling, tugging, mild pinching, intense cold, tingling, stinging, aching and cramping at the treatment site. These sensations subside as the area becomes numb. Following the procedure, typical side effects include redness, swelling, blanching, bruising, firmness, tingling, stinging, tenderness, cramping, aching, itching, skin sensitivity and numbness. Numbness can persist for up to several weeks. A sensation of fullness in the back of the throat may occur after submental treatment. The following rare and very rare side effects have the following reported rates (approximate occurrences per number of treatments): paradoxical hyperplasia (1/3000 [0.033%]); late-onset pain (1/6000 [0.017%]); severe pain (1/6000 [0.017 %]); hyperpigmentation (1/11000 [0.009%]); freeze burn (1/15000 [0.007%]); treatment area demarcation (1/20000 [0.005%]); vasovagal symptoms (1/30000 [0.003%]); subcutaneous induration (1/30000 [0.003%]); cold panniculitis (1/60000 [0.002%]) and hernia (1/185000 [0.001%]).

COOLSCULPTING® and the Snowflake Design are trademarks of Zeltiq Aesthetics, Inc., an AbbVie Company. ©2024 AbbVie. All rights reserved. AbbVie Pty Ltd, ABN 48 156 384 262, having its registered head office at Level 7, 241 O’Riordan Street, Mascot, NSW 2020 and trading as Allergan Aesthetics, an AbbVie Company at Level 20, 177 Pacific Hwy, North Sydney, NSW 2060. AbbVie Limited, NZBN 9429030775923, having its registered head office at Level 6, 156-158 Victoria Street, Wellington, 6011 New Zealand and trading as Allergan Aesthetics, an AbbVie Company.

CS_SNOWFLAKE_white

THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. COOLSCULPTING® IS NOT A WEIGHT LOSS PROCEDURE. IT DOES NOT REPLACE A HEALTHY DIET AND ACTIVE LIFESTYLE.

AU-CSC-230026 V1, Date of Preparation: September 2024.